Frelii Inc. Appoints Two New Members to Its Scientific Advisory Board
February 14, 2019 at 06:17 pm
Share
Frelii Inc. announced that it has appointed two renowned physicians, Anthony R. Torres and Susan H. Morelli M.D., to its Scientific Advisory Board. Torres has been published in dozens of peer-reviewed journals for his work in protein chemistry, molecular biology, the genetics of autism and more. Torres has had an illustrious career not only in university research, but also in the biotechnology field. He also obtained seven patents for novel inventions in numerous areas. Dr. Morelli is a neonatologist at Utah Valley Hospital and is affiliated with multiple hospitals in the area. She is has been published in several journal articles and has been in practice for nearly 25 years. These two individuals are joining the Frelii Inc.Scientific Advisory Board, which includes Dr. Shayne Morris, a molecular biologist and Dr. Hans Jenkins, the Chief Medical Officer of Frelii.
Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.
FRÉLII, INC. 